PT934329E - Glicoconjugados de derivados de camptotecina modificados (ligacao 20-o) - Google Patents
Glicoconjugados de derivados de camptotecina modificados (ligacao 20-o)Info
- Publication number
- PT934329E PT934329E PT97942940T PT97942940T PT934329E PT 934329 E PT934329 E PT 934329E PT 97942940 T PT97942940 T PT 97942940T PT 97942940 T PT97942940 T PT 97942940T PT 934329 E PT934329 E PT 934329E
- Authority
- PT
- Portugal
- Prior art keywords
- ligacao
- glycoconygates
- modified
- derivatives
- camptotecin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19640206 | 1996-09-30 | ||
| DE19643764A DE19643764A1 (de) | 1996-09-30 | 1996-10-23 | Glycokonjugate von modifizierten Camptothecin-Derivaten (20-0-Verknüpfung) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT934329E true PT934329E (pt) | 2002-05-31 |
Family
ID=26029947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97942940T PT934329E (pt) | 1996-09-30 | 1997-09-17 | Glicoconjugados de derivados de camptotecina modificados (ligacao 20-o) |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6492335B1 (pt) |
| EP (1) | EP0934329B1 (pt) |
| JP (1) | JP2001504453A (pt) |
| AT (1) | ATE210673T1 (pt) |
| AU (1) | AU4459297A (pt) |
| CA (1) | CA2267328A1 (pt) |
| DK (1) | DK0934329T3 (pt) |
| ES (1) | ES2169429T3 (pt) |
| PT (1) | PT934329E (pt) |
| WO (1) | WO1998014459A1 (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ID23424A (id) * | 1997-05-14 | 2000-04-20 | Bayer Ag | Glikokonjugat dari 20(s)-kamptotesin |
| DE10005275A1 (de) * | 2000-02-07 | 2001-08-09 | Bayer Ag | Neuartige Glycokonjugate |
| US6350756B1 (en) | 2001-01-18 | 2002-02-26 | California Pacific Medical Center | Camptothecin derivatives |
| US6855720B2 (en) | 2001-03-01 | 2005-02-15 | California Pacific Medical Center | Nitrogen-based camptothecin derivatives |
| US6403604B1 (en) | 2001-03-01 | 2002-06-11 | California Pacific Medical Center | Nitrogen-based camptothecin derivatives |
| US6933302B2 (en) | 2002-06-03 | 2005-08-23 | California Pacific Medical Center | Nitrogen-based homo-camptothecin derivatives |
| GB0329667D0 (en) | 2003-12-22 | 2004-01-28 | King S College London | Core 2 GlcNAc-T inhibitor |
| GB0513881D0 (en) | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors III |
| US20080182801A1 (en) | 2003-12-22 | 2008-07-31 | Btg International Limited | Core 2 glcnac-t inhibitors |
| US7700612B2 (en) * | 2003-12-23 | 2010-04-20 | Abraxis Bioscience, Llc | Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications |
| US20060135546A1 (en) * | 2004-12-16 | 2006-06-22 | Jagadevappa Basavaraja | Methods for the purification of 20(S)- camptothecin |
| GB0513888D0 (en) | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors II |
| US7875602B2 (en) * | 2005-10-21 | 2011-01-25 | Sutter West Bay Hospitals | Camptothecin derivatives as chemoradiosensitizing agents |
| CN102153607B (zh) * | 2010-02-11 | 2015-07-15 | 湖南方盛华美医药科技有限公司 | 水溶性喜树碱衍生物及包含其的药物组合物 |
| JP2021095424A (ja) * | 2018-03-28 | 2021-06-24 | 持田製薬株式会社 | 抗癌剤結合アルギン酸誘導体 |
| CN108822120A (zh) * | 2018-07-11 | 2018-11-16 | 浙江工业大学 | Fl118氨基酸盐酸盐及其制备方法与应用 |
| CN111171041B (zh) * | 2018-11-12 | 2021-07-27 | 中国海洋大学 | 20位取代的喜树碱衍生物及其制备方法和应用 |
| CN115850291A (zh) * | 2021-09-24 | 2023-03-28 | 石药集团巨石生物制药有限公司 | 喜树碱衍生物及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4943579A (en) | 1987-10-06 | 1990-07-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Water soluble prodrugs of camptothecin |
| EP0418099B1 (en) * | 1989-09-15 | 2001-12-19 | Research Triangle Institute | Process of preparation of 10, 11-Methylenedioxy-20 (RS) camptothecin and 10, 11-methylenedioxy-20 (S) - camptothecin analog |
| DE4236237A1 (de) * | 1992-10-27 | 1994-04-28 | Behringwerke Ag | Prodrugs, ihre Herstellung und Verwendung als Arzneimittel |
| ES2149867T3 (es) * | 1993-02-26 | 2000-11-16 | Drug Delivery System Inst Ltd | Derivados de polisacaridos y soportes para farmacos. |
| US6214345B1 (en) * | 1993-05-14 | 2001-04-10 | Bristol-Myers Squibb Co. | Lysosomal enzyme-cleavable antitumor drug conjugates |
| GB9320781D0 (en) * | 1993-10-08 | 1993-12-01 | Erba Carlo Spa | Polymer-bound camptothecin derivatives |
| US5646159A (en) | 1994-07-20 | 1997-07-08 | Research Triangle Institute | Water-soluble esters of camptothecin compounds |
| US5646262A (en) * | 1994-07-28 | 1997-07-08 | Georgetown University | Antisense oligonucleotides against hepatitis B viral replication |
| GB9504065D0 (en) * | 1995-03-01 | 1995-04-19 | Pharmacia Spa | Poly-pyrrolecarboxamidonaphthalenic acid derivatives |
| DE19512484A1 (de) * | 1995-04-04 | 1996-10-17 | Bayer Ag | Kohlenhydratmodifizierte Cytostatika |
| SG50747A1 (en) * | 1995-08-02 | 1998-07-20 | Tanabe Seiyaku Co | Comptothecin derivatives |
| CA2192725C (en) * | 1995-12-28 | 2004-04-20 | Kenji Tsujihara | Camptothecin derivatives |
-
1997
- 1997-09-17 DK DK97942940T patent/DK0934329T3/da active
- 1997-09-17 PT PT97942940T patent/PT934329E/pt unknown
- 1997-09-17 JP JP51618198A patent/JP2001504453A/ja active Pending
- 1997-09-17 AT AT97942940T patent/ATE210673T1/de not_active IP Right Cessation
- 1997-09-17 AU AU44592/97A patent/AU4459297A/en not_active Abandoned
- 1997-09-17 WO PCT/EP1997/005088 patent/WO1998014459A1/de active IP Right Grant
- 1997-09-17 CA CA002267328A patent/CA2267328A1/en not_active Abandoned
- 1997-09-17 EP EP97942940A patent/EP0934329B1/de not_active Expired - Lifetime
- 1997-09-17 US US09/269,317 patent/US6492335B1/en not_active Expired - Fee Related
- 1997-09-17 ES ES97942940T patent/ES2169429T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ATE210673T1 (de) | 2001-12-15 |
| DK0934329T3 (da) | 2002-04-08 |
| EP0934329A1 (de) | 1999-08-11 |
| ES2169429T3 (es) | 2002-07-01 |
| JP2001504453A (ja) | 2001-04-03 |
| EP0934329B1 (de) | 2001-12-12 |
| US6492335B1 (en) | 2002-12-10 |
| CA2267328A1 (en) | 1998-04-09 |
| WO1998014459A1 (de) | 1998-04-09 |
| AU4459297A (en) | 1998-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT934329E (pt) | Glicoconjugados de derivados de camptotecina modificados (ligacao 20-o) | |
| PT939765E (pt) | Glicoconjugados de derivados modificados de camptotecina (ligacao a anel a ou b) | |
| EE03231B1 (et) | Tetratsüklilised derivaadid, nende valmistamismeetod ja kasutamine | |
| TR199900083T2 (xx) | Klaritromisinin kristal bi�imi I. | |
| PL336580A1 (en) | Fine-molecular compounds useful in treating inflammatory diseases | |
| DE69834923D1 (en) | Hochgradig lipophile camptothecin-derivate | |
| IL114294A0 (en) | Sterol derivatives | |
| PL285248A1 (en) | Method of obtaining novel aminophenol derivatives | |
| NO995481D0 (no) | Glykokonjugater av 20 (S)-camptothecin | |
| FI890257A (fi) | Menetelmä terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi | |
| MX9803672A (es) | Nuevos derivados de fenilamidina, procedimiento para su preparacion y su utilizacion como medicamentos. | |
| HUP9900987A3 (en) | Camptothecin derivatives process for their preparation, use thereof as antitumor agents and pharmaceutical compositions containing them | |
| AU641279B2 (en) | Oligosaccharide derivatives | |
| IL129616A0 (en) | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
| GR3025530T3 (en) | Antihypertensive benzopyran derivatives | |
| KR900007816A (ko) | 사이클로프로필-치환된 아졸릴메틸카비놀, 이의 제조방법 및 약제로서의 이의 용도 | |
| IT8822654A0 (it) | Derivati indolici, processo per la loro preparazione e loro uso comefarmaci antitrombotici | |
| IL129625A0 (en) | Novel (-)-enantionmers of CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
| SE9803107D0 (sv) | Novel Compunds | |
| ATE397615T1 (de) | 6-o-alkyl-2-nor-2-substituierte ketolidderivate | |
| DZ1655A1 (fr) | Dérivés de la benzofuranylimidazole ainsi que leurprocédé de préparation. | |
| DZ1472A1 (fr) | Dérivés du glycérol, ainsi que leur de préparation. | |
| FR2704549B1 (fr) | Procédé de préparation de dérivés de la 2-propanone, de la 2-thiopropanone et de la 2-sélénopropanone, en particulier de dérivés des 3-phosphino-1-phosphoranylidène-2-propanone et phosphines ainsi obtenues. |